Archive for November, 2011

HIV Rapid test

HIV Rapid test

HIV Rapid tests are qualitative immunoassays intended for use as a point-of-care test to aid in the diagnosis of HIV infection. This HIV Rapid Test is used in conjunction with the clinical status, history, and risk factors of the person being tested.

We offer the HIV Rapid Test.  This one-step Anti HIV 1, 2 RapidCard™ is a rapid, binding-screening test for the presence of antibodies to HIV 1 and HIV 2 viruses.  It is used as an aid in the diagnosis of HIV infection.  This HIV Rapid Test is based on the principle of inter-second antibody immunoassay for determination of antibodies to HIV-1 and HIV-2 in whole blood/serum/plasma.  Purified recombinant antigens are employed to identify anti-HIV 1 and HIV 2 specifically.  This one step test is very sensitive and only takes 20 minutes for the result to be read. Test results are read visually without any instrument.

 

It’s easy to use.  When you are ready to begin testing, open the sealed pouch of HIV Rapid Test by tearing along the notch. Using the plastic pipette provided, transfer 1 drop of whole blood/serum/plasma to the sample well of the test device. Add 3 drops of diluents provided onto the sample well. Wait for 20 minutes and read the results.

 

Interpretation is simple:  if only one colored band appears on the control (C) region and there is no apparent band on the test (T) region, the result is negative.  If a pink-colored band appears on control (C) and test (T) regions, the result is positive.  If there is no line on control (C) region, the result is considered invalid.

 

As with all diagnostic tests, all results must be considered with other clinical information available to the physician.  A definite clinical diagnosis should only be made by the physician after all clinical and laboratory findings have been evaluated.

 

The HIV Rapid Test should be used for the detection of antibodies to HIV in whole blood/serum/plasma specimen.

 

The HIV Rapid Test Device will only indicate the presence of antibodies to HIV in the specimen and should not be used as the sole criteria for the diagnosis of HIV-1 and/or -2 infections.

 

If the test result is negative and clinical symptoms persist, additional follow-up tests using other clinical methods are recommended. A negative result at any time does not preclude the possibility of HIV -1 and/or -2 infections.

 

Product page :http://www.rapidtest.com/index.php?i=HIV-Rapid-Test-Serum-Cassette&id=385&cat=124

Name

HIV Rapid Test (1&2) Serum (Cassette) RapiCard™ InstaTest

Category Name HIV Rapid Test
Test Bulk Or Boxed in 25 or 50 tests

 

HIV Rapid Test (1&2) Serum (Cassette) RapiCard™ InstaTest

 

callback phone number email us

Malaria Rapid Test kits

Malaria Rapid test

Malaria is a serious parasitic disease characterized by fever, chills, and anemia and is caused by a parasite that is transmitted from one human to another through the bite of infected Anopheles mosquitoes. There are four kinds of malaria that can infect humans: Plasmodium falciparum, P. vivax, P. ovale, and P. malariae. In humans, the parasites (called sporozoites) migrate to the liver where they mature and release another form, the merozoites. The disease now occurs in more than 90 countries worldwide, and it is estimated that there are over 500 million clinical cases and 2.7 million malaria-caused deaths per year.

At present, malaria is diagnosed by looking for the parasites in a drop of blood. Blood will be put onto a microscope slide and stained so that the parasites will be visible under a microscope.

We offer two formats of the test. One test, the Malaria (Pan-LDH) W/B RapiCard™ InstaTest Cat# 172120-25, can detect all four species of malaria Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae. This pan-LDH Antigen Test contains a membrane strip, which is pre-coated with anti-pan LDH monoclonal antibodies on the test line region of the strip. When a Whole Blood specimen is applied at one end of the membrane and following the application of the assay buffer, it reacts with the colloidal gold-anti-pan LDH antibody that has already been applied to the specimen pad. The mixture then migrates chromate-graphically towards the other end of the membrane and reacts with the monoclonal antibodies previously placed on the test line region. If the blood contains one or more of the four Malaria species, a colored line will appear in the test line region, showing a positive result. The absence of the colored line in the test region indicates a negative result; therefore the whole blood does not contain detectable levels of any of the Malaria species.

The other format, Malaria (Pf/Vivax) W/B RapiCard™ InstaTest Cat# 172110-25, will differentiate between the two species: Plasmodium falciparum anf Plasmodium Viavax. This Malaria pf (HRP II) / pv (LDH) Antigen 172110-25 Test contains a membrane strip, which is pre-coated with two monoclonal antibodies as two separate lines across a test strip. One monoclonal antibody (test line 1) is specific to the P. falciparum histidine rich protein-2 (Pf HRP-2) and another monoclonal antibody (test line 2) is specific to the lactate dehydrogenase of the P. vivax species (pvLDH). A Conjugate pad is dispensed with monoclonal antibodies conjugated to colloidal gold, which are specific to P. falciparum histidine rich protein-2 (Pf HRP-2) and specific to the lactate dehydrogenase of P. vivax. Therefore, the antigen of Plasmodium falciparum and Plasmodium vivax can be differentially detected.